| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |